Company profile

Palvella Therapeutics, Inc. Insider Trading

PVLA

Every SEC Form 4 insider trading filing for Palvella Therapeutics, Inc. (PVLA) since April 2023 — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
CIK
0001583648
Filings
66
Insiders
32
Last filing
2026-08-19

Activity summary

No discretionary insider buying or selling in the last 30 days. The 9 transactions filed were made under a 10b5-1 plan, scheduled in advance rather than decided on the day.

Three year balance

Buy and sell value by quarter, Q2 23 to Q3 26. Palvella Therapeutics, Inc. insiders are net sellers across the period shown.

Q2 23Q3 24Q4 24Q1 25Q2 25Q4 25Q1 26Q2 26Q3 26

Bars below the rule are sales, above are purchases. Largest quarter on the chart is $1.5M.

90 day insight

Over the last 90 days, Palvella Therapeutics, Inc. insiders bought $14K across 9 transactions with no open-market sales.

  • Most active insider: Goin Kathleen with 24 transactions totaling $1.9M.
  • Largest single sale: $303K by Goin Kathleen on Aug 19, 2026.
  • 100% of recent sales were pre-scheduled 10b5-1 trades — typically less informative than open-market activity.

Activity skews bullish — buys outpace sales.

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Aug 19, 2026Goin KathleenPVLA
Sale10b5
302$156.77$47K
Aug 19, 2026Goin KathleenPVLA
Option Exercise10b5
2,148
Aug 19, 2026Goin KathleenPVLA
Option Exercise10b5
2,154
Aug 19, 2026Goin KathleenPVLA
Sale10b5
102$155.59$16K
Aug 19, 2026Goin KathleenPVLA
Option Exercise10b5
2,148$9.08$20K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Query this yourself

The same rows, over the API.

curl "https://api.form4api.com/v1/transactions?ticker=PVLA" \
  -H "X-Api-Key: $KEY"
Get a key

Top insiders

By total value filed.

Goin KathleenChief Operating Officer30 filings$2.6M
Korenberg Matthew ECFO, Treasurer1 filing+$14K

Institutional Ownership

Top 13F-HR holders of Palvella Therapeutics, Inc. as of 2026-06-30

↓ decreasing
Total reported AUM
$531.9M
QoQ change
-67.3%
Reporting period
2026-06-30
#1
Jennison Associates LLC
CIK 0000053417
$124.8M
817K shares
#2
State Street Corp
CIK 0000093751
$99.8M
653K shares
#3
BlackRock, Inc.
CIK 0002012383
$63.2M
413K shares

Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →